-- Days : -- HRS : -- MIN : -- SEC

Register Now →

Subscribe

News
Video
Podcasts
Journals
Conferences
Events
Resources
CE
About AJMC
Subscribe

Spotlight -

Free In-Person Regional Events Focused on Oncology and Population Health

John Ellyn, MD

Articles by John Ellyn, MD

An Economic Analysis of Switching to Latanoprost from a Beta-Blocker or adding Brimonidine or Latanoprost to a Beta-Blocker in Open-Angle Glaucoma or Ocular Hypertension

ByWilliam C. Stewart, MD,Jessica Leech, BS,Elizabeth D. Sharpe, MD,John Kulze, MD,John Ellyn, MD,Douglas G. Day, MD

August 1st 2002

Latest Updated Articles

An Economic Analysis of Switching to Latanoprost from a Beta-Blocker or adding Brimonidine or Latanoprost to a Beta-Blocker in Open-Angle Glaucoma or Ocular Hypertension
August 1st 2002

Trending on AJMC

CDC Officially Ends Hantavirus Response as Outbreak Risk Recedes

FDA Approves Sacituzumab Govitecan-hziy for First-Line Metastatic Triple-Negative Breast Cancer

More Women Will Be Diagnosed With MCL Through 2032, SEER Data Suggest

Health Care Spending to Hit $9 Trillion by 2034, According to New Analysis

EHA Data for Epcoritamab Show Durable Responses in Older, Chemotherapy-Ineligible Patients With DLBCL